openPR Logo
Press release

Asia Pacific Bioreactors Market Outlook to 2025: Analysis by Services, Solutions, Users, Industry Verticals, and Regions

08-20-2019 02:38 PM CET | Health & Medicine

Press release from: Graphical Research

Asia Pacific Bioreactors Market Outlook to 2025: Analysis

Asia Pacific bioreactors industry is largely driven by increasing biopharmaceutical investments, rising prevalence of lifestyle diseases such as, cancer and diabetes and growing demand for therapeutically active vaccines. Moreover, technological advancements related to bioreactor material, design and processing will further augment bioreactors market growth over the forecast timeframe.

Request for a sample of this report @

According to the Graphical Research new growth forecast report titled Asia Pacific Bioreactors Market By Technology (Wave-induced Motion SUB, Stirred SUB, Single Use Bubble Column), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Industry Analysis Report, Country Outlook (China, Japan, India, South Korea, Australia, Singapore, Indonesia, Malaysia, Philippines, Thailand) Determined to exceed USD 470 million by 2025.

Major market players in Asia Pacific bioreactors market are Applikon Biotechnology, Inc., Cellexus Limited, CESCO Bioengineering Co. Ltd., Eppendorf AG, GE Healthcare, GEA Group Aktiengesellschaft, Merck Group, PBS Biotech, Inc, Pierre Guerin SAS, Sartorius Stedim Biotech Group, Shanghai Bailun Biotechnology co., Ltd., Solaris Biotech Solutions and Thermo Fisher Scientific Inc. These market players are undertaking strategies such as technology development and acquisitions to gain market presence and for company expansion.

Make an Inquiry for purchasing this Report @

Asia Pacific region is estimated to witness considerable growth due to increasing product innovation coupled with rising government initiatives for the development of healthcare infrastructure. Additionally, developing personalized medicine market will further propel bioreactors market growth in the region.

However, vulnerability to leaching, regulatory concerns regarding single-use bioreactor and limited storage capacity should hinder bioreactor market growth. Additionally, large-scale disposal of plastic derivatives is a growing environmental concern restraining the business growth over the forecast years.

Mammalian cells segment is estimated to expand at 19.1% CAGR over the forecast timeframe. Mammalian cells are used in biopharmaceutical industry for various applications such as, production of monoclonal antibodies from hybridoma cells, retroviral vectors for gene therapy, cultivation of tissue cells for artificial organs, and production of therapeutic and diagnostic glyco-proteins from recombinant cells. Hence, the aforementioned factors will positively impact mammalian cells segmental growth across the forecast timeline.

Browse Table of Contents @

Recombinant protein segment generated over USD 18.1 million in 2018. High growth is attributed to growing applications of recombinant proteins in the treatment of several diseases, including different types of cancer and rheumatic conditions. Moreover, increasing focus of biopharmaceutical companies in novel approaches for the purification, characterization and expression of recombinant proteins will further drive product demand.

Single-use bubble column segment is expected to witness substantial growth rate of 19.3% across the forecast timeframe. High growth is attributed to their complex hydrodynamics and influence on transport characteristics. The single use bubble column technology offer advantages such as high heat transfer and mass transfer rates, compactness, and low maintenance and operating costs, thus augmenting market growth.

Biopharma manufacturers segment was valued at USD 47.3 million in 2018 and is projected to witness strong growth over the forecast years. High growth is attributed to increasing number of biopharmaceutical companies in the developing economies. Additionally, growing establishments of new facilities to meet the production needs will also initiate positive market growth.

Japan is estimated to hold majority revenue share of 28.7% in 2018 and is anticipated to grow at a significant growth rate in the coming years. Increasing number of biopharmaceutical companies responsible for bringing new medicines to patients and their collaborations with academic institutions and venture capital firms will accelerate the Japan bioreactors market during the forecast period. Moreover, increasing financial support from the government for development of novel drugs will further support bioreactors market growth.

Browse key industry insights from this Report @

Asia Pacific Bioreactors Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Asia Pacific Bioreactors Market Share, By Cell, 2014-2025, (USD Million)
Mammalian cells
Bacterial cells
Yeast cells

Asia Pacific Bioreactors Market Size, By Molecule, 2014-2025, (USD Million)
Monoclonal antibodies
Recombinant protein
Stem cell
Gene therapy

Asia Pacific Bioreactors Market Trend, By Technology, 2014-2025, (USD Million)
Wave-induced motion SUB
Stirred SUB
Stirred-use bubble column

Asia Pacific Bioreactors Market Value, By End-use, 2014-2025, (USD Million)
Research and development (R&D) organizations
Biopharma manufacturers
Contract manufacturing organizations (CMOs)

Contact Us:
Parikhit B.
Corporate sales,
Graphical Research

About Graphical Research:
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific Bioreactors Market Outlook to 2025: Analysis by Services, Solutions, Users, Industry Verticals, and Regions here

News-ID: 1824038 • Views: 320

More Releases from Graphical Research

Europe Breast Implant Market: Advanced Technologies & Growth Opportunities World …
Europe breast implant market is projected to grow at a lucrative rate in the forecast period due to improving positive perception towards cosmetic surgeries. Growing cases of breast cancer will also augment the demand for breast implantation. Breast cancer is the most common cancer in females. Desired results for breast implants can be achieved with current technological advancement. Breast implantation procedures results to improved self-image and self-confidence. Above mentioned factors
Saudi Arabia High Performance Films Market 2019: Evolving Technology, Trends and …
Growing construction activities triggered by rapid industrialization is expected to propel the high-performance films market size. Governments focus on development of key economic sectors including tourism and transport will further support the industry development. As per Saudi Arabia Ministry of Finance, 6% of total planned budget of USD 260 billion has been allotted for infrastructure and transportation sector in 2018. Strong demand in building and construction products such as exterior
Asia Pacific Ambulatory Surgical Centers Market to be worth more than USD 13 Bn …
Ambulatory surgical centers (ASCs) offers superior quality, professionalism and safety that is one of the prominent reason physicians and patients are choosing ASCs. Furthermore, convenient scheduling and reliable service are attracting majority of patients and physicians towards ambulatory settings. Additionally, researches show that quality of care delivered by ASCs is similar or in some cases even better than hospital care. Aforementioned benefits offered by ASCs along with lower patient complications
Digital Health Market in Asia Pacific to witness $80.7 bn by 2024
Countries in Asia Pacific such as China, India, Philippines, Malaysia have initiated several government programs for creating awareness among patients and physicians for digital health solutions. Rising investment in development of telecommunication network coupled with development of healthcare infrastructure will boost regional growth across the forecast timeframe. According to the Graphical Research new growth forecast report titled “Asia Pacific Digital Health Market“ Analysis based on Technology [Tele-healthcare {Telecare (Activity Monitoring,

All 5 Releases

More Releases for Asia

RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
MES: Expansion in Asia
Berlin, November 24, 2014: Model Engineering Solutions (MES), the Berlin-based specialist for model-based software development, has significantly expanded its business in Asia. In recent years, MES has built up a network of local partners in Japan, Korea, China, and India in order to benefit from the growing market and increasing interest in model-based development and ISO 26262 in Asia. Asia: Driving force in the automotive industry The automotive industry continues
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
UDT Asia 2011
Clarion Events hosts the Undersea Defence Technology (UDT) Asia 2011 conference and exhibition to bring senior naval and industry personnel together to cover underwater developments in the region Singapore, May 30 – Clarion Events is hosting UDT Asia on 30 November – 1 December 2011. The event brings together the undersea defence community in Asia, featuring top regional naval speakers, who will be addressing the latest underwater requirements for Asian navies. According
eltherm goes Asia
Finally all preparations are finished and the new subsidiary of eltherm GmbH, eltherm Asia Pacific Pte Ltd has commenced operations in Singapore on 1st April 2010. To celebrate the starting shot, an opening celebration was held in the afternoon of 28th July in the office premises followed by a get together dinner and drinks in the evening at a pub. A total of 62 guests attended the event with the